Learn and Connect with C5’s Life Sciences IP Portfolio Advisory Board:
C5’s Global Life Sciences IP Advisory board was created as a part of C5’s ongoing effort to provide industry leading content and a world renowned speaker faculty. The board is composed of a selection of advisers from around the globe, including leading pharmaceutical and biotech companies. This ‘inner circle’ counsels C5 on the impact of litigation trends and emerging topics.

Dominic Adair

Partner
Bristows LLP (U.K)

Co-Chairs’ Opening Remarks

February 24, 2022 9:00 am

Monika Dorda

SVP & General Counsel Global Pharmaceuticals
GSK

Sabrina Duschner

Head of Patent Litigation Strategy
Fresenius Kabi

Bert Oosting

Partner
Hogan Lovells

Co-Chairs’ Opening Remarks

February 24, 2022 9:00 am

Guido Pontremoli, Ph.D.

Global IP Head
Corp. Intellectual Property-Patents
Chiesi Farmaceutici S.p.A.

Shohta Ueno, PhD

Director, Dispute Resolution
Regeneron UK Ltd